BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 6204738)

  • 1. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck.
    Ensley JF; Jacobs JR; Weaver A; Kinzie J; Crissman J; Kish JA; Cummings G; Al-Sarraf M
    Cancer; 1984 Sep; 54(5):811-4. PubMed ID: 6204738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction chemotherapy with cisplatinum, 5-fluorouracil, bleomycin, mitomycin C and hydroxyurea for previously untreated locally advanced squamous cell carcinomas of the head and neck.
    Fountzilas G; Nicolaou A; Sridhar K; Sideras T; Haritanti A; Anastasakis C; Delis V; Vritsios A; Daniilidis J
    Arch Otorhinolaryngol; 1989; 246(5):373-7. PubMed ID: 2480104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
    Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined modality therapy utilizing a cisplatin combination for effective chemotherapy in patients with previously untreated head and neck cancer.
    Jacobs JR; Kish J; Ensley JF; Ahmad K; Weaver A; Crissman J; Al-Sarraf M
    Am J Surg; 1986 Oct; 152(4):451-5. PubMed ID: 2429570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-containing chemotherapy in advanced head and neck cancer.
    Paterson IC; Quilty PM
    Clin Radiol; 1985 Nov; 36(6):607-10. PubMed ID: 2415291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer.
    Cognetti F; Pinnarö P; Ruggeri EM; Carlini P; Perrino A; Impiombato FA; Calabresi F; Chilelli MG; Giannarelli D
    J Clin Oncol; 1989 Jul; 7(7):829-37. PubMed ID: 2472469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer.
    Cognetti F; Pinnarò P; Carlini P; Ruggeri EM; Ambesi Impiombato F; Del Vecchio MR; Giannarelli D; Perrino A
    Cancer; 1988 Jul; 62(2):251-61. PubMed ID: 2454721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
    Clavel M; Cognetti F; Dodion P; Wildiers J; Rosso R; Rossi A; Gignoux B; Van Rymenant M; Cortes-Funes H; Dalesio O
    Cancer; 1987 Sep; 60(6):1173-7. PubMed ID: 2441836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of chemotherapy in advanced head and neck cancer.
    Spaulding MB; Loré JM; Sundquist N
    Arch Otolaryngol Head Neck Surg; 1989 Jan; 115(1):68-73. PubMed ID: 2462437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy prior to definitive local therapy in squamous cell carcinoma of the head and neck.
    Adelstein DJ; Hines JD; Sharan VM; Streeter RR; Earle AS; Haria CD; Carter SG; Shah AC; Vlastou C; Damm C
    Oncology; 1985; 42(2):80-5. PubMed ID: 2581202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
    Recloux P; Dodion PF; Andry G; Chantrain G; Dor P; Buyse M; Van Houtte P; Lemort M; Haesendonck P; Larsimont D
    Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of head and neck cancer].
    Kohno N; Nakazawa E; Kusunoki M; Nishiya M
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region.
    Fountzilas G; Daniilidis J; Sridhar KS; Kalogera-Fountzila A; Zaramboukas T; Sombolos K; Destouni-Salem E; Vritsios A; Tourkantonis A
    Cancer; 1990 Oct; 66(7):1453-60. PubMed ID: 1698526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy with cisplatin-bleomycin and subsequent radiotherapy in advanced head and neck tumors].
    Schmieder A; Jacobs H; Maurer H; Pfeifer H
    Klin Wochenschr; 1984 Jan; 62(1):35-42. PubMed ID: 6199553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
    J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck.
    Rozencweig M; Dodion P; Bruntsch U; Gallmeier W; Clavel M; Gignoux B; Cortes Funes H; Cavalli F; Kirkpatrick A; Dalesio O
    Cancer; 1984 Oct; 54(8):1499-503. PubMed ID: 6206936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
    J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.
    Keil F; Selzer E; Berghold A; Reinisch S; Kapp KS; De Vries A; Greil R; Bachtiary B; Tinchon C; Anderhuber W; Burian M; Kasparek AK; Elsäßer W; Kainz H; Riedl R; Kopp M; Kornek G
    Eur J Cancer; 2013 Jan; 49(2):352-9. PubMed ID: 22981499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of complete responders after initial treatment with chemotherapy in head and neck cancer.
    Kies MS; Gordon LI; Hauck WW; Krespi Y; Ossoff RH; Pecaro BC; Yuska C; Lamut CH; Brand WN; Chang SK
    Otolaryngol Head Neck Surg; 1985 Apr; 93(2):199-205. PubMed ID: 2581211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.